Clinical Updates

NASA has signed an agreement with a California-based startup to develop and market a nasal spray for motion sickness,… »   

U.S. drug reviewers found three serious concerns related to NPS Pharmaceuticals Inc’s experimental drug for short bowel syndrome but said… »   

Sanofi’s Genzyme unit has received positive feedback from U.S. doctors after the recent launch of multiple sclerosis pill Aubagio and… »   

GlaxoSmithKline, criticized in the past for keeping important information about its medicines to itself, is to lift the lid on… »   

GlaxoSmithKline and the non-profit biotech group Aeras are to assess an experimental tuberculosis vaccine in “proof of concept” tests in… »   

Many drugs work by “fixing” a particular biological pathway that’s gone awry in a disease. But sometimes drugs affect other… »   

Targacept Inc said it would cut its workforce to 43, or by about 38 percent, due to the failure of… »   

EU regulators will decide next year whether to fine Danish drugmaker Lundbeck and French peer Servier for blocking the entry… »   

A University of Michigan biophysical chemist and his colleagues have discovered the smallest and fastest-known molecular switches made of RNA,… »   

Novartis is keen to maintain its dividend and is looking to boost growth via mid-sized acquisitions, though big deals… »   

Drugmakers Sanofi and Bristol-Myers Squibb plan to revamp their 15-year-old alliance from January 1 in response to lost exclusivity on… »   

Loading up on vitamin D is unlikely to prevent the common cold this winter, a new study from New Zealand… »   

A two-drug combination bested monotherapy for metastatic melanoma, resulting in a 60% reduction in the odds of progression, according to… »   

Abbott Laboratories for years misstated that the executive handpicked to head its pending pharmaceutical spinoff held both bachelor’s and… »   

A mid-stage trial of a new treatment from Novartis helped alleviate the symptoms for people suffering from plaque psoriasis, the… »